Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition

[1]  W. Regine,et al.  Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases , 2020, Radiation Oncology.

[2]  L. Hansen,et al.  Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study. , 2020, Journal of neurosurgery.

[3]  James B. Yu,et al.  Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases. , 2020, Journal of neurosurgery.

[4]  J. Beijnen,et al.  Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review , 2019, BMC Cancer.

[5]  G. Barnett,et al.  The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis. , 2019, Neuro-oncology.

[6]  C. Whitlow,et al.  Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. , 2019, Neuro-oncology practice.

[7]  P. Brown,et al.  Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  K. McDonald,et al.  Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis , 2018, Journal of Neuro-Oncology.

[9]  Suneel D. Kamath,et al.  Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease , 2018, Front. Oncol..

[10]  H. Shih,et al.  Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases. , 2018, International journal of radiation oncology, biology, physics.

[11]  C. Bettegowda,et al.  Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. , 2017, International journal of radiation oncology, biology, physics.

[12]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.